C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
11/2001
11/08/2001	CA2407796A1 Cdk inhibitors having 3-hydroxychromen-4-one structure
11/08/2001	CA2407587A1 Ppar.gamma. modulators
11/08/2001	CA2407334A1 Lipochroman-6 as no-synthase inhibitor and uses
11/08/2001	CA2407189A1 New gamma selective retinoids
11/07/2001	EP1150968A1 Method for producing phytosterols
11/07/2001	EP1150960A1 Polymorphic crystalline forms of celecoxib
11/07/2001	EP1150959A1 Solid-state form of celecoxib having enhanced bioavailability
11/07/2001	EP1150944A1 N2-phenylamidine derivatives
11/07/2001	EP1042312B1 PHOTOCHROMIC INDENO-FUSED NAPHTHO[2,1-b]PYRANS
11/07/2001	EP0801750B1 Novel substituted phenanthropyrans
11/07/2001	EP0714296B1 Flavonoid and biflavonoid derivatives, their pharmaceutical compositions, their anxiolytic activity
11/06/2001	US6313173 Glyoxylic acid amides
11/06/2001	US6313163 Administering 2,4-pentadienoic acid derivative for therapy of disease or condition responsive to therapy by retinoids
11/06/2001	US6313160 Substituted heterocyclic compounds, method for preparing and compositions containing same
11/06/2001	US6313142 Method for making 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline
11/06/2001	US6313107 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
11/06/2001	US6313088 Carriers used to deliver various active agents through various biological, chemical, and physical barriers
11/01/2001	WO2001081328A2 Thiazolidinedione analogues and their use for the treatment of diabetes
11/01/2001	WO2001041762A3 Valdecoxib compositions
11/01/2001	WO2001041761A3 Valdecoxib compositions
11/01/2001	US20010037039 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant
11/01/2001	US20010037037 Oximesulfonic acid esters and the use thereof as latent sulfonic acids
11/01/2001	US20010037025 Benzopyran, benzothiopyran or benzoquinone derivatives are useful in the treatment of ailments and disorders where a reduction of blood glucose is benefical, such as diabetes
11/01/2001	US20010036936 Compositions and methods for treating osteoporosis
11/01/2001	US20010036487 Proanthocyanidin-containing composition
11/01/2001	CA2402123A1 Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
10/2001
10/31/2001	EP1149834A1 Diaminopyrimidines, pharmaceutical compositions containing them and their use as antibacterial
10/31/2001	EP1149066A1 Method of preparing alkylated salicylamides
10/31/2001	EP0929543B1 Herbicidal composition
10/31/2001	CN1319597A Method for separating catechin compound from theopolyphenols
10/31/2001	CN1073848C Ginkgo flavone internal ester extract and preparation process thereof
10/30/2001	US6310248 Process and intermediates
10/30/2001	US6310080 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
10/30/2001	US6310074 Substituted dimeric compounds
10/30/2001	US6309678 Process for isolation of hepatoprotective agent silymarin from the seeds of the plant Silybum marianum
10/25/2001	WO2001079157A1 Hydrazide and alkoxyamide angiogenesis inhibitors
10/25/2001	WO2001078529A2 Compositions and methods for improving vascular health
10/25/2001	WO2001027099A3 Bicyclic compounds composition and method for stabilizing the same
10/25/2001	WO2001021608A3 Novel flavonoids
10/25/2001	US20010034448 New compounds, their preparation and use
10/25/2001	US20010033944 Light-emitting material for organo-electroluminescence device and for organic electroluminescence device which the material is applied
10/25/2001	CA2406442A1 Hydrazide and alkoxyamide angiogenesis inhibitors
10/24/2001	EP1147764A2 Cosmetic composition
10/24/2001	EP1147100A1 Recovery of chroman derivatives
10/24/2001	EP1147080A1 Alkynyl containing hydroxamic acid compounds as tace inhibitors
10/24/2001	EP0975618B1 a new process for the preparation of 3-N,N-dicycobutylamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide
10/24/2001	EP0842928B1 Process for producing isochroman compounds
10/24/2001	EP0834497B1 Process for producing 3-isochromanones
10/24/2001	CN1319092A Benzamide derivatives and their use as cytokine inhibitors
10/24/2001	CN1318544A Inhibitor used as antioxygen and 5-lipoxygenase, and anti-inflammatory non-steroid carboxylic ester and amide of non-steroid anti-inflammatory agent
10/24/2001	CN1318371A New use of flavone
10/24/2001	CN1318366A Cosmetics composition
10/24/2001	CN1073562C Method for extracting material containing raw anthocyanidin from ginkgo leaf by supercritical carbon dioxide
10/23/2001	US6306868 Methods for inhibiting the growth of tumors with 7-substituted camptothecin derivatives
10/23/2001	US6306587 Template-directed photoligation
10/23/2001	CA2107150C Chromenic derivatives having a triene lateral chain, process for the preparation thereof and pharmaceutical compositions containing them
10/18/2001	WO2001076595A1 Intracorporeal medicaments for high energy phototherapeutic treatment of disease
10/18/2001	WO2001076570A2 Use of substances that act as cascade inhibitors of the raf/mek/erk signal cascade, for producing a medicament to treat dna and rna viruses
10/18/2001	WO2001076567A1 Method and composition for treating cancer by administration of apoptosis-inducing chemotherapeutic agents
10/18/2001	US20010031881 Using a catalyst system comprising an aqueous hydrohalic acid, a zinc halide, and optionally an elemental metal such as zinc, with acetic acid as the solvent; catalyst can be separated and recycled by simple phase separation
10/18/2001	US20010031782 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease
10/18/2001	US20010031735 Flavonoide esters and their use notably in cosmetics
10/18/2001	DE10013782A1 4-Fluoralkyl-2H-benzopyrane mit antiestrogener Wirksamkeit, Verfahren zu ihrer Herstellung, pharmazeutische Präparate, die diese enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln 4-fluoroalkyl-2H-benzopyrans with antiestrogenic action, processes for their preparation, pharmaceutical compositions containing them and their use for the preparation of medicaments
10/18/2001	CA2406484A1 Method and composition for treating cancer by administration of apoptosis-inducing chemotherapeutic agents
10/18/2001	CA2405554A1 Intracorporeal medicaments comprising halogenated xanthenes for high energy phototherapeutic treatment of disease
10/18/2001	CA2405307A1 Application of substances acting as cascade inhibitors of the raf/mek/erk signaling cascade for the production of a drug against infections by dna and rna viruses
10/17/2001	EP1143986A2 Plant-derived anti-parasitic and antifungal compounds and methods of extracting the compounds
10/17/2001	EP0942911B1 Benzopyranopyrrole and benzopyranopyridine alpha-1 adrenergic compounds
10/17/2001	EP0865438B1 Oxymethoxy-3-aryl-pyrone derivatives
10/17/2001	CN1318064A Method for preparing vitamin E
10/17/2001	CN1317972A Compsn contg. rutin and quercetin for preventing or treating elevated blood lipid level-related diseases
10/17/2001	CN1317964A Composition
10/17/2001	CN1317486A Process for preparing sematron by aceton method
10/16/2001	US6303797 Sesterterpene derivatives exhibiting antifungal activities
10/16/2001	US6303796 Chemical intermediates; optically active compounds useful as optical resolution agents; metal-coordinated compounds useful as asymmetric catalysts
10/16/2001	US6303785 Substituted n-cyclopropyltetrahydroisoquinolines
10/16/2001	US6303775 Polynucleotides labelled with asymmetric benzoxanthene dyes
10/16/2001	US6303583 Continuous injection of 5-fluorouracil (5fu) for 3 to 48 hours once a week and oral administration of a mixture of 1-(tetrahydrofuryl)-5-fluorouracil and uracil (uft) one to four times a day for 3 to 7 days per week for cancer therapy
10/16/2001	CA2075632C Chromene derivatives, their production and use
10/16/2001	CA2042673C Acetyl-tri- and tetramethyl-octahydronaphthalenes and fragrance compositions containing the same
10/11/2001	WO2001074753A1 Synthetic derivatives of lunularic acid, medicaments containing said compounds, method for producing the lunularic acid derivatives and the use thereof
10/11/2001	US20010029248 Composition for and method of reducing low density lipoprotein cholesterol concentration
10/11/2001	DE10110455A1 Sensitizer for tumor treatment contains a xanthene dye structure and a structure with at least one hydrophilic group and at least one lipophilic group bound to one and the same carbon atom in the molecule
10/11/2001	DE10017480A1 Verwendung von Substanzen, die als MEK Inhibitor wirken, zur Herstellung eines Arneimittels gegen DNA- und RNA-Viren Use of substances that act as MEK inhibitor for the manufacture of a Arneimittels against DNA and RNA viruses
10/11/2001	DE10015525A1 Synthetische Derivate von Lunularsäure, Arzneimittel enthaltend diese Verbindung, Verfahren zur Herstellung der Lunularsäurederivate sowie deren Verwendung Synthetic derivatives of Lunularsäure, to medicaments containing this compound, methods of making them and their use of the Lunularsäurederivate
10/10/2001	EP1142887A1 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents
10/10/2001	EP1142870A1 Novel ligands of nuclear receptor
10/10/2001	EP1142857A1 Processes for producing acrylic acid derivative
10/10/2001	EP1141137A1 Water-soluble rhodamine dyes and conjugates thereof
10/10/2001	EP1140893A1 Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process
10/10/2001	EP1140892A1 Photochromic substiituted 2h-naphtho[1,2-b]pyrans
10/10/2001	EP1140890A1 Chroman derivatives
10/10/2001	EP1140889A2 Compounds and methods for modulation of estrogen receptors
10/10/2001	EP1140888A1 Optical molecular sensors for cytochrome p450 activity
10/10/2001	EP1140791A2 Selective cpla 2 inhibitors
10/10/2001	EP1140181A1 Combination therapy of radiation and a cox-2 inhibitor for the treatment of neoplasia
10/10/2001	EP1140067A1 Antiviral method using mek inhibitors
10/10/2001	EP1140065A1 Use of gamma-tocopherol and its oxidative metabolite llu-alpha in the treatment of disease
10/10/2001	EP1140042A1 Utilization of inhibitors of the kqt1 channel in order to produce a medicament for treating diseases which are caused by parasitic helminths and ectoparasites
10/10/2001	EP1051170B1 Application of substituted aminomethyl chromans in order to prevent neural degeneration and to promote neural regeneration

1 ... 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 ... 242